Comparison of strategies to overcome the hypertensive effect of combretastatin-A4 phosphate in a rat model

被引：0
|
作者：
Honess, DJ
Hylands, F
Chaplin, DJ
Tozer, GM
机构：
[1] Oxigene Inc, Watertown, MA 02472 USA
[2] Mt Vernon Hosp, Gray Canc Inst, Tumor Microcirculat Grp, Northwood HA6 2JR, Middx, England
来源：
BRITISH JOURNAL OF CANCER | 2002年 / 86卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S118 / S119
页数：2
相关论文
共 50 条
  • [21] OXI 4503 a novel vascular targeting agent: Effects on bloodflow and antitumor activity in comparison to Combretastatin A-4 phosphate
    Edvardsen, K
    Hua, J
    Sheng, Y
    Pinney, K
    Kane, R
    Prezioso, J
    Chaplin, D
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S43 - S43
  • [22] Tumour parameters affected by combretastatin A-4 phosphate therapy in a human colorectal xenograft model in nude mice
    El-Emir, E
    Petrie, IA
    Boxer, GM
    Boden, R
    Dearling, JLJ
    Raleigh, JA
    Mantavani, A
    Green, AJ
    Begent, RHJ
    Pedley, RB
    BRITISH JOURNAL OF CANCER, 2002, 86 : S112 - S112
  • [23] Tumour parameters affected by combretastatin A-4 phosphate therapy in a human colorectal xenograft model in nude mice
    El-Emir, E
    Boxer, GM
    Petrie, IA
    Boden, RW
    Dearling, JLJ
    Begent, RHJ
    Pedley, RB
    EUROPEAN JOURNAL OF CANCER, 2005, 41 (05) : 799 - 806
  • [24] Three Different Strategies to Obtain Porous Calcium Phosphate Cements: Comparison of Performance in a Rat Skull Bone Augmentation Model
    Klijn, Reinoud J.
    van den Beucken, Jeroen J. J. P.
    Lanao, Rosa P. Felix
    Veldhuis, Gert
    Leeuwenburgh, Sander C.
    Wolke, Joop G. C.
    Meijer, Gert J.
    Jansen, John A.
    TISSUE ENGINEERING PART A, 2012, 18 (11-12) : 1171 - 1182
  • [25] Development of cell therapy strategies to overcome copper toxicity in the LEC rat model of Wilson disease
    Malhi, Harmeet
    Joseph, Brigid
    Schilsky, Michael L.
    Gupta, Sanjeev
    REGENERATIVE MEDICINE, 2008, 3 (02) : 165 - 173
  • [26] The vascular response of tumor and normal tissues in the rat to the vascular targeting agent, combretastatin A-4-phosphate, at clinically relevant doses
    Prise, VE
    Honess, DJ
    Stratford, MRL
    Wilson, J
    Tozer, GM
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2002, 21 (04) : 717 - 726
  • [27] EFFECT OF VERAPAMIL ON SPLANCHNIC HEMODYNAMICS IN A PORTAL HYPERTENSIVE RAT MODEL
    LAY, CS
    TSAI, YT
    YANG, CM
    CHEN, HI
    SIMCHON, S
    CHIEN, S
    LO, KJ
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1990, 5 (02) : 141 - 148
  • [28] Effect of verapamil on renal haemodynamics in a portal hypertensive rat model
    Lay, CS
    Yang, MCM
    Wu, SL
    Tsai, YT
    Wu, KL
    Chien, S
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1996, 11 (04) : 391 - 395
  • [29] Effect of glycine in an experimental model of hypertensive and hypertriglyceridemic rat.
    Valdez, R
    Carvajal, K
    Banos, G
    HYPERTENSION, 1997, 29 (03) : 178 - 178
  • [30] Antitumor effect of combretastatin A-4 derivative, AC7700, against rat liver cancer
    Ohno, T
    Kawano, K
    Tahara, K
    Aramaki, M
    Sasaki, A
    Takeuchi, Y
    Kai, S
    Ishio, T
    Kitano, S
    GASTROENTEROLOGY, 2001, 120 (05) : A557 - A557
12345